A research study to evaluate the kinetics of mobilisation of blood stem cells and circulating tumour cells in response to docetaxel chemotherapy and pegfilgrastim.
Phase of Trial: Phase II
Latest Information Update: 29 Jun 2016
At a glance
- Drugs Docetaxel (Primary) ; Pegfilgrastim (Primary)
- Indications Advanced breast cancer
- Focus Pharmacodynamics
- 29 Jun 2016 New trial record